FOXF1
Basic information
Region (hg38): 16:86510527-86515422
Previous symbols: [ "FKHL5" ]
Links
Phenotypes
GenCC
Source:
- alveolar capillary dysplasia with misalignment of pulmonary veins (Definitive), mode of inheritance: AD
- alveolar capillary dysplasia with misalignment of pulmonary veins (Supportive), mode of inheritance: AD
- alveolar capillary dysplasia with misalignment of pulmonary veins (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Alveolar capillary dysplasia with misalignment of pulmonary veins | AD | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Genitourinary; Gastrointestinal; Musculoskeletal; Pulmonary | 15520767; 19500772; 20425831; 22990143; 23407133; 23444129; 23505205; 24842713 |
ClinVar
This is a list of variants' phenotypes submitted to
- Alveolar capillary dysplasia with pulmonary venous misalignment (11 variants)
- not provided (7 variants)
- FOXF1-related disorder (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FOXF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 23 | ||||
missense | 36 | 53 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 11 | 15 | ||||
inframe indel | 7 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 17 | |||||
Total | 18 | 11 | 49 | 24 | 18 |
Variants in FOXF1
This is a list of pathogenic ClinVar variants found in the FOXF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-86510566-C-T | FOXF1-related disorder | Likely benign (Feb 25, 2020) | ||
16-86510568-C-T | Alveolar capillary dysplasia with pulmonary venous misalignment | Uncertain significance (Oct 26, 2018) | ||
16-86510583-C-T | Inborn genetic diseases | Uncertain significance (Oct 12, 2024) | ||
16-86510585-G-C | Inborn genetic diseases | Uncertain significance (May 23, 2023) | ||
16-86510589-AG-A | Alveolar capillary dysplasia with pulmonary venous misalignment | Pathogenic (May 06, 2021) | ||
16-86510600-C-T | Inborn genetic diseases | Uncertain significance (Mar 28, 2024) | ||
16-86510601-C-A | FOXF1-related disorder | Uncertain significance (Dec 03, 2022) | ||
16-86510604-ACGG-A | Likely benign (Sep 01, 2023) | |||
16-86510604-ACGGCGG-A | Uncertain significance (Oct 25, 2022) | |||
16-86510604-ACGGCGGCGG-A | Uncertain significance (Aug 28, 2023) | |||
16-86510604-A-ACGG | Alveolar capillary dysplasia with pulmonary venous misalignment • FOXF1-related disorder | Conflicting classifications of pathogenicity (Oct 01, 2024) | ||
16-86510604-A-ACGGCGGCGGCGG | FOXF1-related disorder | Uncertain significance (Aug 30, 2024) | ||
16-86510607-G-T | Inborn genetic diseases | Uncertain significance (Jul 05, 2023) | ||
16-86510608-C-CGGCGGA | Uncertain significance (Sep 27, 2022) | |||
16-86510615-G-A | Inborn genetic diseases | Uncertain significance (Dec 14, 2021) | ||
16-86510615-G-GGGCGGCGGCGGCGGGGGA | Alveolar capillary dysplasia with pulmonary venous misalignment | Uncertain significance (Mar 30, 2021) | ||
16-86510623-CGGCG-C | Alveolar capillary dysplasia with pulmonary venous misalignment | Pathogenic (-) | ||
16-86510623-C-CG | Pathogenic (Aug 04, 2020) | |||
16-86510625-G-GCCC | Uncertain significance (Mar 10, 2023) | |||
16-86510626-CGGG-C | Alveolar capillary dysplasia with pulmonary venous misalignment | Conflicting classifications of pathogenicity (Nov 01, 2024) | ||
16-86510639-G-A | Inborn genetic diseases | Uncertain significance (Dec 26, 2023) | ||
16-86510642-GC-G | Pathogenic (Jan 19, 2018) | |||
16-86510654-G-T | Inborn genetic diseases | Uncertain significance (Oct 03, 2023) | ||
16-86510658-C-A | Alveolar capillary dysplasia with pulmonary venous misalignment | Pathogenic (Oct 01, 2019) | ||
16-86510658-C-T | Inborn genetic diseases | Uncertain significance (Nov 13, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FOXF1 | protein_coding | protein_coding | ENST00000262426 | 2 | 3944 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.958 | 0.0420 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.09 | 161 | 205 | 0.786 | 0.00000978 | 2406 |
Missense in Polyphen | 26 | 63.587 | 0.40889 | 775 | ||
Synonymous | -2.15 | 119 | 92.7 | 1.28 | 0.00000469 | 764 |
Loss of Function | 2.92 | 0 | 9.91 | 0.00 | 4.49e-7 | 115 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable transcription activator for a number of lung- specific genes.;
- Disease
- DISEASE: Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]: A rare developmental disorder characterized by abnormal development of the capillary vascular system in the lungs. Histological features include failure of formation and ingrowth of alveolar capillaries, medial muscular thickening of small pulmonary arterioles with muscularization of the intraacinar arterioles, thickened alveolar walls, and anomalously situated pulmonary veins running alongside pulmonary arterioles and sharing the same adventitial sheath. Less common features include a reduced number of alveoli and a patchy distribution of the histopathologic changes. Affected infants present with respiratory distress and the disease is fatal within the newborn period. Additional features include multiple congenital anomalies affecting the cardiovascular, gastrointestinal, genitourinary, and musculoskeletal systems, as well as disruption of the normal right-left asymmetry of intrathoracic or intraabdominal organs. ACDMPV is a rare cause of persistent pulmonary hypertension of the newborn, an abnormal physiologic state caused by failure of transition of the pulmonary circulation from the high pulmonary vascular resistance of the fetus to the low pulmonary vascular resistance of the newborn. {ECO:0000269|PubMed:19500772, ECO:0000269|PubMed:23505205, ECO:0000269|PubMed:27145217}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- FOXA2 and FOXA3 transcription factor networks
(Consensus)
Recessive Scores
- pRec
- 0.203
Haploinsufficiency Scores
- pHI
- 0.359
- hipred
- Y
- hipred_score
- 0.837
- ghis
- 0.479
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.849
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Foxf1
- Phenotype
- muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; embryo phenotype; respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- foxf1
- Affected structure
- vascular lymphangioblast
- Phenotype tag
- abnormal
- Phenotype quality
- absent
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;blood vessel development;vasculogenesis;in utero embryonic development;somitogenesis;morphogenesis of a branching structure;positive regulation of mesenchymal cell proliferation;endocardial cushion development;cardiac left ventricle morphogenesis;smoothened signaling pathway;determination of left/right symmetry;midgut development;heart development;positive regulation of cell-substrate adhesion;detection of wounding;extracellular matrix organization;respiratory tube development;lung development;positive regulation of cell migration;pancreas development;negative regulation of mast cell degranulation;establishment of epithelial cell apical/basal polarity;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;lung alveolus development;lateral mesodermal cell differentiation;embryonic digestive tract morphogenesis;digestive tract development;embryonic ectodermal digestive tract morphogenesis;embryonic foregut morphogenesis;negative regulation of inflammatory response;smooth muscle cell differentiation;regulation of smooth muscle cell differentiation;lung vasculature development;trachea development;epithelial tube branching involved in lung morphogenesis;right lung morphogenesis;lung lobe morphogenesis;venous blood vessel development;epithelial cell differentiation involved in mammary gland alveolus development;cellular response to cytokine stimulus;cellular response to organic cyclic compound;renal system development;ureter development;mesenchyme migration;ductus arteriosus closure;cell-cell adhesion
- Cellular component
- nucleus;transcription factor complex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;sequence-specific DNA binding